ABSTRACT: Background. Patients with head and neck malignancies who have had solid organ transplant and require free tissue transfer are a unique population. This study was performed to evaluate the effect of immunosuppression on the rate of perioperative complications and the success of free tissue transfer in the head and neck. Methods. Complications in solid organ transplant patients undergoing free tissue transfer for reconstruction of head and neck malignancies from 1998 to 2010 were evaluated. Results. A total of 22 flaps in 17 patients were performed. Eight patients (11 of 22 flaps) had complications. The median hospital stay was 6 days (range, 4-26 days). The median length of follow-up was 13.5 months (range, 3.5-49.9 months). Conclusions. Solid organ transplant patients are at an increased risk of de novo malignancies due to chronic immunosuppression. This study demonstrates that free tissue transfer is a viable option in transplant patients with morbidity similar to nontransplant patients.
Solid organ transplant patients with head and neck malignancies requiring free tissue transfer are a unique population. The number of solid organ transplants in the United States increased by 29% from 1998 to 2007 (Scientific Registry of Transplant Recipients). 1 Patient 5-year graft survival rates after single solid organ transplantation range from 36.3% to 80.7% (Scientific Registry of Transplant Recipients) and continue to increase. The use of immunosuppressive agents increases the risk of de novo malignancy, including cutaneous malignancies. [2] [3] [4] [5] There is a cumulative risk of cutaneous malignancy reported at 5% per year. 6 The increasing number of organ transplants and rates of graft survival will likely lead to greater rates of de novo malignancies. Organ transplant patients with head and neck malignancies occasionally require free tissue transfer for reconstruction of large defects.
The presence of comorbidities potentially affecting wound healing is an important consideration in the preoperative workup. 7 Potential factors that may compromise wound healing include smoking, diabetes, malnutrition, previous irradiation, and immunosuppression. [8] [9] [10] Initiation of the inflammatory cascade is an essential step in wound healing. Immunosuppression has been shown to affect wound healing through inhibition of necessary inflammatory mediators. 11 A recent study of free tissue transfer in solid organ transplant patients was performed, but the majority of the reconstruction sites were in distal extremities (11 of 19) with relatively few head and neck patients (5 of 19). 12 This study was performed to evaluate the effect of immunosuppression on the rate of perioperative complications and success of free tissue transfer in the head and neck.
MATERIALS AND METHODS
We performed a retrospective review of all solid organ transplant patients undergoing elective free tissue transfer for head and neck malignancies between 1998 and 2010 at the Oregon Health and Science University and the University of Alabama at Birmingham. Institutional review board approval was obtained at the respective institutions. Seventeen patients were identified and included in the study. Eleven patients were identified at Oregon Health and Science University and 6 patients at University of Alabama at Birmingham. Patient age at the time of surgery, sex, primary malignancy, tumor stage, type of free flap reconstruction, transplanted organ(s), immunosuppression regimen, length of hospital stay, postoperative complications, and length of postoperative follow-up were evaluated. Complication outcomes included: flap failure, partial flap necrosis, wound infection, donor site or recipient site complications, hematoma, and seroma. Major complications were categorized as those requiring operative intervention or contributing to a prolonged hospital course.
RESULTS
Seventeen patients had free tissue transfer after resection of head and neck malignancies. The median age of patients at the time of surgery was 62 years (range, 18-78 years) and a majority of patients were men (71%). Solid organ transplantation varied, with renal transplants composing the majority of patients (65%; Table 1 ). Patients had oral cavity squamous cell carcinoma (SCC; 29%), cutaneous SCC (47%), malignant fibrous histiocytoma (12%), basal cell carcinoma (6%), and spindle cell carcinoma (6%). The majority of flaps (59%) were performed after ablation of advanced T classification tumors, T3 or T4 ( Table 2) . Among the oral cavity SCC group, 2 patients were TNM stage II and 3 patients were stage III/IVa. The cutaneous SCC group had 2 patients with stage II, 7 patients with stage III, and 1 patient with stage IV disease. In addition, 27% of flaps were performed for recurrent lesions. A total of 22 flaps were performed, with 3 patients receiving 2 flaps, and 1 patient receiving 3 flaps. A representative case is provided in Figure 1 , with anterolateral thigh free flap reconstruction of a large soft tissue defect after wide local excision. The majority of flaps used for reconstruction were radial forearm (36%) and anterolateral thigh flaps (32%; Table 3 ). Most patients (59%) had extensive tumor resections, with wide local excision in addition to concurrent ablative surgery ( Table 4 ). The types of immunosuppressive medications used are listed in Table 5 . Only 1 patient was not on an immunosuppressive regimen at the time of free tissue transfer. There were postoperative complications in 8 patients and 11 of 22 (50%) flaps (Table 6) . Of these complications, 45% were considered major and occurred in 24% of patients. Previous irradiation to the recipient site was present in 36% of all patients, and in 45% of flaps experiencing complications. The median hospital stay was 6 days (range, 4-26 days). There was not a significant difference between the mean hospital stay in the patient group experiencing flap complications (7.9 6 6.2 days) when compared to those not experiencing complications (6.1 6 1.2; p ¼ .35). The median length of followup was 13.5 months (range, 3.5-49.9 months). Survival was 29.4% at the time of last follow-up, with the deceased cohort surviving a median of 14.4 months (range, 3.2-49.9 months). Tx  1  5  T1  0  0  T2  3  14  T3  3  14  T4  10  45 Note: Not included are 3 patients that had flaps for malignant fibrous histiocytoma (no TNM staging system exists) and 1 patient that had 2 flaps due to osteoradionecrosis. 
DISCUSSION
Solid organ transplant patients are at an increased risk of de novo malignancies due to chronic immunosuppression. [2] [3] [4] [5] [6] These patients will occasionally require free tissue transfer for coverage of large defects. 13 Overall published free tissue transfer failure rates are 1% to 9%, 14 but there are limited reports on failure rates in patients on immunosuppressive regiments. The flap failure rate in the current study is 4.5%.
Although there is a low rate of overall flap failure, a higher rate of complications exist. The impact of flap failure in the current series is demonstrated by patient 1, who had multiple complications and hospitalizations. She had complications associated with all 3 free flap reconstructions. The last 2 free flaps were performed in an irradiated surgical field. In addition, she had a failed pedicled latissimus flap and wound dehiscence after a pedicled pectoralis flap. This resulted in a mean hospital stay of 13 days compared to the overall average hospital stay of 7 days.
Postoperative complications are common in the overall free tissue transfer population, with a recently reported rate of 29% to 33.5% in reconstruction of head and neck patients. 10, 15 A recent multicenter case series evaluating free tissue transfer in the solid organ transplant population had a complication rate of 42%, although the majority of flaps were performed on extremities in patients with peripheral vascular disease and diabetes. 12 This group of patients also had an average hospital stay of 10.5 days compared to 7.0 days in our cohort. This may indicate a population with greater comorbidities, including peripheral vascular disease and diabetes. The reason for free tissue transfer was not fully described. Some patients received free tissue transfer after malignancy extirpation, while others received flaps for treatment of chronic wounds. The mean follow-up was 6.8 years compared to 17.2 months in our cohort. The patients included in the current study represent a different patient population with respect to complications. Another study by Moran et al 16 analyzed the contribution of renal failure and uremiainduced immunosuppression on free tissue transfer complications and survival. They had a 6% rate of primary free flap failure, with several other patients subsequently losing flaps to complications of progressive lower extremity ischemia. They noted immediate postoperative complications in 44% of their patients. They also had a high rate of diabetes (88%) and peripheral vascular disease (84%), compared to a diabetes rate of 24% in our cohort. Our study has a similar complication rate in head and neck patients treated with immunosuppressive medications.
Patient selection for free flap reconstruction includes assessment of comorbidities that may affect wound healing, including the immunosuppression regimen of solid organ transplant patients. Postoperative wound complications are reported to be increased with the use of rapamycin (sirolimus) compared to mycophenolate mofetil, tacrolimus, and cyclosporine-based regimens. 17, 18 The increase of wound complications and lymphocele formation in patients on sirolimus is in exchange for decreased acute graft rejection and potential decreased risk of de novo malignancy. Only 10.8% of kidney transplant patients from 2006 had sirolimus included in their immunosuppressive regimen at 1-year follow-up. 1 Although only 2 patients in the current cohort were on sirolimus, both experienced postoperative flap complications, including 1 seroma.
Other factors that may affect the rate of complications in our cohort include the presence of previous irradiation, compromising the vascularity of the recipient site. Yu et al 19 examined the outcomes of 1266 patients and reported a rate of radiation before free tissue transfer in 44% of patients. They found no significant difference in the rates of free flap failure between the nonirradiated and radiated groups. The rate of other complications, such as wound infection, wound dehiscence, hematoma, and seroma was not specifically addressed. There is a reported significant increase in postoperative complications in patients having prior irradiation to the free tissue recipient site. 9 Cohn et al 20 found a major complication rate of 66% in 35 patients who had a second round of radiation therapy before reconstruction. The overall flap success rate was 94%.
CONCLUSION
Although there was a 50% postoperative flap complication rate, there was only a 4.5% flap failure rate. Of the complications experienced, 45% were considered major and occurred in 24% of patients. The majority of our patients presented with aggressive disease, resulting in significant ablative defects and poor survival. Free tissue transfer for reconstruction of complex head and neck defects is a viable option in transplant patients with failure rates similar to nontransplant patients. 
